Livanova said Monday a trial of its obstructive sleep apnea (OSA) implant met its primary safety and efficacy endpoints, positioning the company to seek approval once the analysis is complete. The ...

The RingConn Gen 2 has a sleep apnea detection feature, which can advise if it notices breathing disturbances overnight and ...

Lilly is currently waiting for the U.S. Food and Drug Administration’s (FDA’s) decision to expand the use of tirzepatide to ...

Needham analyst Michael Matson has maintained their bullish stance on LIVN stock, giving a Buy rating on October 31. Michael Matson has given ...

This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimer’s disease, liver disease ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome to the Axsome Therapeutics Third ...

Medical technology company SoundHealth has launched SONUCheck, a vocal analysis feature in the SONU app that uses AI to ...

Anthony Petrone’s rating is based on several promising developments regarding LivaNova’s OSPREY study for treating obstructive sleep apnea (OSA). The company announced favorable 6-month results from ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have ...

For the second time in less than a year, the FDA has issued a complete response letter to the company, citing the need for data on a third-party manufacturing site that had failed an earlier ...